The role of DRE in the diagnosis of prostate carcinoma.
DRE has been used as a diagnostic and screening tool for prostate cancer for decades. However these are based on Western data and its local applicability has yet to be verified. We held a Prostate Health Awareness Week in August 1998 and a total of 2086 men were screened. All men aged 50 years old and above were included for the study. The subjects were evaluated on DRE findings, PSA levels and if indicated a TRUS-guided biopsy results. We concluded that DRE per se might have limited role in the screening of prostate cancer in Malaysia. Screening using DRE and PSA combined are still recognized as the most cost-effective means. Neither DRE nor PSA alone has high enough specificity for diagnosis of prostate cancer cases. Combining DRE and PSA will definitely increase the specificity significantly.
Chong
W L
WL
Institute of Urology, Kuala Lumpur Hospital, Jalan Pahang, 50586 Kuala Lumpur.
Sahabudin
R M
RM
Teh
G C
GC
Woo
S Y
SY
Lim
T C
TC
Khairullah
A
A
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008296:Malaysia; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology*; D012007:Rectum / Q000473:pathology*; D012680:Sensitivity and Specificity
D017430:Prostate-Specific Antigen